Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noushin Nabavi

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Non-Coding RNA Research|March 22, 2024
Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanismMehrdad Hashem, Elaheh Mohandesi Khosroshahi, Melika Aliahmady, et al.
Translational Oncology|October 2, 2024
Highlighting function of Wnt signalling in urological cancers: Molecular interactions, therapeutic strategies, and (nano)strategiesMehrdad Hashemi, Mahdi Rezaei, Hadi Rezaeiaghdam, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 11, 2023
Stimuli-responsive (nano)architectures for phytochemical delivery in cancer therapyMohammad Arad Zandieh, Melika Heydari Farahani, Mahshid Daryab, et al.
European Journal of Pharmacology|July 25, 2023
PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulationSahar Rezaei, Negin Nikpanjeh, Aryan Rezaee, et al.
Non-Coding RNA Research|September 19, 2024
Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancerMehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Saba Asadi, et al.
Translational Oncology|December 2, 2023
Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancerMehrdad Hashemi, Nastaran Esbati, Mohsen Rashidi, et al.
Pathology, Research and Practice|November 3, 2023
New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesisMehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.
Environmental Research|September 2, 2023
Graphene oxide nanoarchitectures in cancer therapy: Drug and gene delivery, phototherapy, immunotherapy, and vaccine developmentMohammad Saleh Sadeghi, Faezeh Hosseini Sangrizeh, Negar Jahani, et al.
Non-Coding RNA Research|December 25, 2024
Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: Recent insights and potential clinical applicationsMehrdad Hashemi, Asal Abolghasemi Fard, Bita Pakshad, et al.
Pharmacological Research|November 24, 2022
Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agentsMehrdad Hashemi, Motahare Sadat Ayat Mirdamadi, Yasmin Talebi, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Non-Coding RNA Research|March 22, 2024
Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanismMehrdad Hashem, Elaheh Mohandesi Khosroshahi, Melika Aliahmady, et al.
Translational Oncology|October 2, 2024
Highlighting function of Wnt signalling in urological cancers: Molecular interactions, therapeutic strategies, and (nano)strategiesMehrdad Hashemi, Mahdi Rezaei, Hadi Rezaeiaghdam, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 11, 2023
Stimuli-responsive (nano)architectures for phytochemical delivery in cancer therapyMohammad Arad Zandieh, Melika Heydari Farahani, Mahshid Daryab, et al.
European Journal of Pharmacology|July 25, 2023
PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulationSahar Rezaei, Negin Nikpanjeh, Aryan Rezaee, et al.
Non-Coding RNA Research|September 19, 2024
Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancerMehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Saba Asadi, et al.
Translational Oncology|December 2, 2023
Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancerMehrdad Hashemi, Nastaran Esbati, Mohsen Rashidi, et al.
Pathology, Research and Practice|November 3, 2023
New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesisMehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.
Environmental Research|September 2, 2023
Graphene oxide nanoarchitectures in cancer therapy: Drug and gene delivery, phototherapy, immunotherapy, and vaccine developmentMohammad Saleh Sadeghi, Faezeh Hosseini Sangrizeh, Negar Jahani, et al.
Non-Coding RNA Research|December 25, 2024
Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: Recent insights and potential clinical applicationsMehrdad Hashemi, Asal Abolghasemi Fard, Bita Pakshad, et al.
Pharmacological Research|November 24, 2022
Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agentsMehrdad Hashemi, Motahare Sadat Ayat Mirdamadi, Yasmin Talebi, et al.
Pageof 10